Irbesartan Abz

Irbesartan, the active ingredient in Irbesartan Abz, is an angiotensin II receptor blocker presented as an oral dosage form for oral administration. It works by selectively blocking AT1 receptors, which helps to lower elevated blood pressure and reduces progression of kidney damage in patients with diabetic nephropathy.

GNH USA supplies Irbesartan Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Irbesartan acts on the renin‑angiotensin‑aldosterone system to control blood pressure and protect renal function.

- Hypertension: lowers systolic and diastolic blood pressure in adults with essential hypertension. - Diabetic nephropathy: slows the decline of renal function in patients with type 2 diabetes and proteinuria. - Renal protection in type 2 diabetes: reduces progression of kidney disease associated with diabetic nephropathy.

Common Side Effects: - Dizziness: feeling light‑headed, especially after the first dose. - Headache: mild to moderate intensity. - Fatigue: general tiredness without a clear cause. - Upper respiratory tract infection: nasopharyngitis or mild cough. - Hyperkalemia (mild): elevated serum potassium levels.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat requiring immediate medical attention. - Severe hyperkalemia: markedly high potassium that can affect cardiac rhythm. - Acute renal failure: sudden decline in kidney function. - Hepatic injury: abnormal liver enzymes or hepatitis. - Myocardial infarction (rare): chest pain or cardiac events.

Before initiating therapy, consider the following precautions: - Blood pressure monitoring: check baseline and periodic readings to avoid hypotension. - Renal function assessment: evaluate serum creatinine and eGFR, especially in patients with existing kidney disease. - Serum potassium: monitor levels to detect hyperkalemia early. - Pregnancy: contraindicated in pregnancy (Category D) due to fetal toxicity risk. - Elderly patients: start at lower doses and monitor for orthostatic symptoms. - Store at room temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Irbesartan may interact with several medicines that affect potassium balance or renal function.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): combined use can increase renal impairment and hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - ACE inhibitors (e.g., enalapril): additive effect on potassium and renal function.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance antihypertensive effect, requiring dose adjustment. - CYP2C9 inhibitors (e.g., fluconazole): can increase irbesartan plasma concentrations. - NSAIDs (e.g., ibuprofen): may reduce antihypertensive efficacy and affect renal function.